The Economic Value of Rotavirus Vaccination When Optimally Implemented in a High-Income Country

por Standaert, Baudouin
Publicado 2023

Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium...

por Standaert, Baudouin
Publicado 2023

Discounting health gain: a different view

por Standaert, Baudouin, Ethgen, Olivier
Publicado 2023

2. How is the economic assessment of vaccines performed today?

por Standaert, Baudouin, Rappuoli, Rino
Publicado 2017

3. How comprehensive can we be in the economic assessment of vaccines?

por Standaert, Baudouin, Rappuoli, Rino
Publicado 2017

Towards a more comprehensive approach for a total economic assessment of vaccines?: 1. The building blocks for a health economic assessment of vaccination

por Standaert, Baudouin, Rappuoli, Rino
Publicado 2017

Defining the Recipe for an Optimal Rotavirus Vaccine Introduction in a High-Income Country in Europe

por Standaert, Baudouin, Benninghoff, Bernd
Publicado 2022

Improving the Hospital Quality of Care during Winter Periods by Optimizing Budget Allocation Between Rotavirus Vaccination and Bed Expansion

por Dort, Thibaut, Schecroun, Nadia, Standaert, Baudouin
Publicado 2017

Budget constraint and vaccine dosing: a mathematical modelling exercise

por Standaert, Baudouin A, Curran, Desmond, Postma, Maarten J
Publicado 2014

Exploring the potential impact of rotavirus vaccination on work absenteeism among female administrative personnel of the City of Antwerp through a retrospective database analysis

por Standaert, Baudouin, Van de Mieroop, Els, Nelen, Vera
Publicado 2015

Dissecting the indirect effects caused by vaccines into the basic elements

por Scarbrough Lefebvre, Carla D, Terlinden, Augustin, Standaert, Baudouin
Publicado 2015

Medium- to Long-Term Impact of Rotavirus Vaccination on Hospital Care in Belgium: A 7-Year Follow-Up of the Rotavirus Belgium Impact Study (RotaBIS)

por Standaert, Baudouin, Strens, Danielle, Alwan, Ali, Raes, Marc
Publicado 2015

The temporal impact of aging on the burden of herpes zoster

por Varghese, Lijoy, Standaert, Baudouin, Olivieri, Antonio, Curran, Desmond
Publicado 2017

Public health impact of accelerated immunization against rotavirus infection among children aged less than 6 months in the United States

por Weycker, Derek, Atwood, Mark Andrew, Standaert, Baudouin, Krishnarajah, Girishanthy
Publicado 2014

Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany?

por Knoll, Stefanie, Mair, Christoph, Benter, Ursula, Vouk, Katja, Standaert, Baudouin
Publicado 2013

Comparing Cost-Effectiveness Results for a Vaccine Across Different Countries Worldwide: What Can We Learn?

por Standaert, Baudouin, Ethgen, Olivier, Emerson, Rachel, Postma, Maarten, Mauskopf, Josephine
Publicado 2014

The Sustained Rotavirus Vaccination Impact on Nosocomial Infection, Duration of Hospital Stay, and Age: The RotaBIS Study (2005–2012)

por Standaert, Baudouin, Strens, Danielle, Li, Xiao, Schecroun, Nadia, Raes, Marc
Publicado 2016

Lessons Learned from Long-Term Assessment of Rotavirus Vaccination in a High-Income Country: The Case of the Rotavirus Vaccine Belgium Impact Study (RotaBIS)

por Standaert, Baudouin, Strens, Danielle, Pereira, Priya, Benninghoff, Bernd, Raes, Marc
Publicado 2020

Comparing the Analysis and Results of a Modified Social Accounting Matrix Framework with Conventional Methods of Reporting Indirect Non-Medical Costs

por Standaert, Baudouin, Sauboin, Christophe, Leclerc, Quentin J., Connolly, Mark P.
Publicado 2020

A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancer

por Demarteau, Nadia, Detournay, Bruno, Tehard, Bertrand, El Hasnaoui, Abdelkader, Standaert, Baudouin
Publicado 2010